Research Progress on the Relationship between Hypertensive Disorders of Pregnancy and Stillbirth

doi:10.12280/gjfckx.20250195

Abstract

Abstract:

Stillbirth is one of the severe complications of pregnancy. The occurrence of stillbirth not only brings huge psychological burdens and harm to pregnant women and their families but also imposes relatively large economic burden on society. Hypertensive disorders of pregnancy (HDP) are one of the common complications during pregnancy. Recent studies have shown that HDP is one of the important maternal factors leading to stillbirth. However, little is known about the influence of different hypertension classifications on HDP and stillbirth. The relationship between blood pressure control levels and stillbirth remains controversial, and there are also disputes about whether the use of drugs such as aspirin in the treatment of HDP in pregnant women is beneficial. This review summarizes the influence of HDP on stillbirth, the impact of drug treatment for HDP on stillbirth, the mechanism by which HDP leads to stillbirth, and the management of stillbirth caused by HDP, aiming to provide more scientific and accurate guidance for the prevention and management of stillbirth.

Key words: Pregnancy, Hypertension, Hypertension, pregnancy-induced, Fetal death, Therapy, Pregnancy management

YAO Zheng-yang, WU Shao-wen, LIU Rui-xia, YIN Cheng-hong. Research Progress on the Relationship between Hypertensive Disorders of Pregnancy and Stillbirth[J]. Journal of International Obstetrics and Gynecology, 2025, 52(4): 377-383.

References 41

[1]	应豪, 谢涵. “三孩”生育政策下产科面临的挑战和应对举措[J]. 中国实用妇科与产科杂志, 2023, 39(6):577-580. doi: 10.19538/j.fk2023060101.
[2]	Lopian M, Kashani-Ligumsky L, Many A. A Balancing Act: Navigating Hypertensive Disorders of Pregnancy at Very Advanced Maternal Age, from Preconception to Postpartum[J]. J Clin Med, 2023, 12(14):4701. doi: 10.3390/jcm12144701.
[3]	Guarga Montori M, Álvarez Martínez A, Luna álvarez C, et al. Advanced maternal age and adverse pregnancy outcomes: A cohort study[J]. Taiwan J Obstet Gynecol, 2021, 60(1):119-124. doi: 10.1016/j.tjog.2020.11.018. pmid: 33494983
[4]	Zhou Y, Yin S, Sheng Q, et al. Association of maternal age with adverse pregnancy outcomes: A prospective multicenter cohort study in China[J]. J Glob Health, 2023, 13:04161. doi: 10.7189/jogh.13.04161. pmid: 38038697
[5]	Dah AK, Osarfo J, Ampofo GD, et al. Stillbirth incidence and determinants in a tertiary health facility in the Volta Region of Ghana[J]. PLoS One, 2023, 18(12):e0296076. doi: 10.1371/journal.pone.0296076.
[6]	Boerma T, Campbell O, Amouzou A, et al. Maternal mortality, stillbirths, and neonatal mortality: a transition model based on analyses of 151 countries[J]. Lancet Glob Health, 2023, 11(7): e1024-e1031. doi: 10.1016/S2214-109X(23)00195-X. pmid: 37349032
[7]	刘瑞霞, 李双影, 阴赪宏. 重视因出生缺陷导致的围产儿死亡[J]. 中华医学杂志, 2024, 104(26):2378-2382. doi: 10.3760/cma.j.cn112137-20231224-01474.
[8]	GBD 2021 Global Stillbirths Collaborators. Global, regional, and national stillbirths at 20 weeks′ gestation or longer in 204 countries and territories, 1990—2021: findings from the Global Burden of Disease Study 2021[J]. Lancet, 2024, 404(10466):1955-1988. doi: 10.1016/S0140-6736(24)01925-1.
[9]	Nakamya P, Komakech A, Migamba SM, et al. Trends and geospatial distribution of stillbirths in Uganda, 2014—2020[J]. BMC Pregnancy Childbirth, 2024, 24(1):249. doi: 10.1186/s12884-024-06434-x.
[10]	王小新, 邹丽颖. 死胎的病因分析及预防复发性死胎的策略[J]. 中国医刊, 2023, 58(7):709-710. doi: 10.3969/j.issn.1008-1070.2023.07.005.
[11]	San Lazaro Campillo I, Meaney S, McNamara K, et al. Psychological and support interventions to reduce levels of stress, anxiety or depression on women′s subsequent pregnancy with a history of miscarriage: an empty systematic review[J]. BMJ Open, 2017, 7(9):e017802. doi: 10.1136/bmjopen-2017-017802.
[12]	Magee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2022, 27:148-169. doi: 10.1016/j.preghy.2021.09.008.
[13]	Pankiewicz K, Szczerba E, Maciejewski T, et al. Non-obstetric complications in preeclampsia[J]. Prz Menopauzalny, 2019, 18(2):99-109. doi: 10.5114/pm.2019.85785. pmid: 31485207
[14]	Malik A, Jee B, Gupta SK. Preeclampsia: Disease biology and burden, its management strategies with reference to India[J]. Pregnancy Hypertens, 2019, 15:23-31. doi: 10.1016/j.preghy.2018.10.011. pmid: 30825923
[15]	Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2020, 76(14):1690-1702. doi: 10.1016/j.jacc.2020.08.014. pmid: 33004135
[16]	徐霞, 许艳红, 祖逸峥, 等. 先于子痫前期的严重胎儿生长受限的临床特点及围产结局[J]. 中华围产医学杂志, 2024, 27(9):722-728. doi: 10.3760/cma.j.cn113903-20240521-00366.
[17]	Kajdy A, Sys D, Modzelewski J, et al. Evidence of Placental Aging in Late SGA, Fetal Growth Restriction and Stillbirth-A Systematic Review[J]. Biomedicines, 2023, 11(7):1785. doi: 10.3390/biomedicines11071785.
[18]	Redman C, Staff AC, Roberts JM. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways[J]. Am J Obstet Gynecol, 2022, 226(2S):S907-S927. doi: 10.1016/j.ajog.2020.09.047.
[19]	Bhardwaj M, Leli NM, Koumenis C, et al. Regulation of autophagy by canonical and non-canonical ER stress responses[J]. Semin Cancer Biol, 2020, 66:116-128. doi: 10.1016/j.semcancer.2019.11.007. pmid: 31838023
[20]	杨清凤, 知诗卓玛, 刘继红. 子痫前期与宫内死胎的相关性研究进展[J]. 中国卫生标准管理, 2022, 13(1):191-195. doi: 10.3969/j.issn.1674-9316.2022.01.054.
[21]	胡艳君, 李晓庆, 徐晓敏, 等. 妊娠期高血压疾病凝血指标和vWF的变化与意义[J]. 现代实用医学, 2019, 31(1):11-13,17. doi: 10.3969/j.issn.1671-0800.2019.01.005.
[22]	Xiong T, Mu Y, Liang J, et al. Hypertensive disorders in pregnancy and stillbirth rates: a facility-based study in China[J]. Bull World Health Organ, 2018, 96(8):531-539. doi: 10.2471/BLT.18.208447.
[23]	Lisonkova S, Razaz N, Sabr Y, et al. Maternal risk factors and adverse birth outcomes associated with HELLP syndrome: a population-based study[J]. BJOG, 2020, 127(10):1189-1198. doi: 10.1111/1471-0528.16225.
[24]	Al Khalaf SY, O′Reilly ÉJ, McCarthy FP, et al. Pregnancy outcomes in women with chronic kidney disease and chronic hypertension: a National cohort study[J]. Am J Obstet Gynecol, 2021, 225(3):298.e1-298.e20. doi: 10.1016/j.ajog.2021.03.045.
[25]	Wong S, Tse WT, Lau SL, et al. Stillbirth rate in singleton pregnancies: a 20-year retrospective study from a public obstetric unit in Hong Kong[J]. Hong Kong Med J, 2022, 28(4):285-293. doi: 10.12809/hkmj219361. pmid: 35058373
[26]	Nisar MI, Kabole I, Khanam R, et al. Does the implementation of revised American College of Cardiology and American Heart Association (ACC/AHA) guidelines improve the identification of stillbirths and preterm births in hypertensive pregnancies: a population-based cohort study from South Asia and sub-Saharan Africa[J]. BMC Pregnancy Childbirth, 2024, 24(1):451. doi: 10.1186/s12884-024-06637-2.
[27]	Yang Y, Xie Y, Li M, et al. Characteristics and fetal outcomes of pregnant women with hypertensive disorders in China: a 9-year national hospital-based cohort study[J]. BMC Pregnancy Childbirth, 2022, 22(1):924. doi: 10.1186/s12884-022-05260-3.
[28]	中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期血压管理中国专家共识(2021)[J]. 中华妇产科杂志, 2021, 56(11):737-745. doi: 10.3760/cma.j.cn112141-20210506-00251.
[29]	Magee LA, Smith GN, Bloch C, et al. Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management[J]. J Obstet Gynaecol Can, 2022, 44(5):547-571.e1. doi: 10.1016/j.jogc.2022.03.002. pmid: 35577426
[30]	Avalos LA, Neugebauer RS, Nance N, et al. Maternal and neonatal outcomes associated with treating hypertension in pregnancy at different thresholds[J]. Pharmacotherapy, 2023, 43(5):381-390. doi: 10.1002/phar.2778.
[31]	Smith GC, Shah I, White IR, et al. Previous preeclampsia, preterm delivery, and delivery of a small for gestational age infant and the risk of unexplained stillbirth in the second pregnancy: a retrospective cohort study, Scotland, 1992-2001[J]. Am J Epidemiol, 2007, 165(2):194-202. doi: 10.1093/aje/kwj354. pmid: 17065276
[32]	Ananth CV, Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality[J]. Epidemiology, 2010, 21(1):118-123. doi: 10.1097/EDE.0b013e3181c297af. pmid: 20010214
[33]	Mbah AK, Alio AP, Marty PJ, et al. Pre-eclampsia in the first pregnancy and subsequent risk of stillbirth in black and white gravidas[J]. Eur J Obstet Gynecol Reprod Biol, 2010, 149(2):165-169. doi: 10.1016/j.ejogrb.2009.12.035. pmid: 20080330
[34]	Hoffman MK. The great obstetrical syndromes and the placenta[J]. BJOG, 2023, 130(Suppl 3):8-15. doi: 10.1111/1471-0528.17613.
[35]	李健鑫, 陈真, 漆洪波. 阿司匹林预防子痫前期:从证据到应用规范[J]. 中华围产医学杂志, 2024, 27(4):265-271. doi: 10.3760/cma.j.cn113903-20240115-00024.
[36]	徐婷婷, 邓春艳, 周凡, 等. 低剂量阿司匹林对子痫前期高危人群预防效果的系统评价研究[J]. 中华妇幼临床医学杂志(电子版), 2014, 10(5):585-593. doi: 10.3877/cma.j.issn.1673-250.2014.05.006.
[37]	Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622. doi: 10.1056/NEJMoa1704559.
[38]	Foster AB, Park F, Hyett J. Do first-trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre-term preeclampsia: A systematic review and meta-analysis[J]. Prenat Diagn, 2023, 43(7):950-958. doi: 10.1002/pd.6394.
[39]	乔娟, 漆洪波. 美国妇产科医师学会“死胎管理专家共识2020版”要点解读[J]. 中国实用妇科与产科杂志, 2020, 36(10):1025-1029. doi: 10.19538/j.fk2020100126.
[40]	Wen T, Breslin N, Overton EE, et al. Risk of Stillbirth after Antepartum Hospitalization for Hypertensive Diseases of Pregnancy[J]. Am J Perinatol, 2020, 37(1):66-72. doi: 10.1055/s-0039-1697589. pmid: 31563137
[41]	von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2016, 36:83-102. doi: 10.1016/j.bpobgyn.2016.05.005. pmid: 27531686